Rilzabrutinib: all 21 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal FunctionRecruitingNCT07853131Phase 1
• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related DiseaseRecruitingNCT07190196Phase 3
• A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic AnemiaRecruitingNCT07086976Phase 3
• Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line TreatmentRecruitingNCT07007962Phase 3
• A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseRecruitingNCT06984627Phase 2
• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell DiseaseRecruitingNCT06975865Phase 3
• A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseRecruitingNCT06500702Phase 2
• Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 AntihistamineCompletedNCT05107115Phase 2Results posted
• Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic DermatitisCompletedNCT05018806Phase 2Results posted
• Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)CompletedNCT04562766Phase 3Results posted
• A Study of PRN1008 in Patients With PemphigusTerminatedNCT03762265Phase 3Results posted
• A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)CompletedNCT03395210Phase 2Results posted
• A Study of PRN1008 in Adult Patients With Pemphigus VulgarisCompletedNCT02704429Phase 2Results posted
• An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 InhibitionActive, not recruitingNCT07855250Phase 1
• Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in JapanActive, not recruitingNCT07216079Phase 3
• A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)CompletedNCT06444204Phase 1
• Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian SubjectsCompletedNCT06444191Phase 1
• A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy ParticipantsCompletedNCT06342700Phase 1
• Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe AsthmaCompletedNCT05104892Phase 2
• Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)Active, not recruitingNCT05002777Phase 2
• Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease ParticipantsCompletedNCT04520451Phase 2

← Rilzabrutinib overview